Crossmark

Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?

Crossref DOI link: https://doi.org/10.1186/s12879-019-4056-6

Published Online: 2019-05-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dimi, Svetlane https://orcid.org/0000-0002-3434-5846
Zucman, David

Chassany, Olivier

Lalanne, Christophe

Prazuck, Thierry

Mortier, Emmanuel

Majerholc, Catherine

Aubin-Auger, Isabelle

Verger, Pierre

Duracinsky, Martin
License Information

Text and Data Mining valid from 2019-05-09
More Information

Article History

Received: 6 January 2018

Accepted: 1 May 2019

First Online: 9 May 2019

Ethics approval and consent to participate

: All subjects provided their written consent prior to the study. Questionnaires and interviews were fully anonymous. A favorable ethical opinion was obtained from the relevant French Ethics Committee (IDRCB 2013-A01344–41).

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.